Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes

NCT05419908 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Hot Flashes

Interventions

DRUG: Fezolinetant
DRUG: Placebo

Sponsor

Ogeda S.A.